Bovine spongiform encephalopathy, Creutzfeldt-Jakob disease, sheep scrapie and chronic wasting disease (CWD) of deer, elk and moose are members of a class of fatal, neurodegenerative diseases known as transmissible spongiform encephalopathies (TSEs) or prion diseases. The infectious agent appears to be primarily, if not solely, comprised of a misfolded isoform of the prion protein, designated PrP TSE . TSE agents are remarkably stable; most treatments that inactivate other infectious agents fail to eliminate prion infectivity (Taylor, 2000) . Scrapie and CWD differ from other TSEs in that epizootics can be maintained by horizontal transmission from infected to naïve animals (Hoinville, 1996; Miller & Williams, 2003) and be mediated by an environmental reservoir of infectivity (Greig, 1940; Miller & Williams, 2003) . Infection of naïve sheep with scrapie following exposure to potentially contaminated environments is well established (Greig, 1940; Pálsson, 1979; Georgsson et al., 2006) and experiments with mule deer suggest a similar mode of transmission is possible with CWD (Miller et al., 2004) .
The lack of clear evidence for vector-mediated TSE transmission prompted investigation of soil as a reservoir of prion infectivity (Schramm et al., 2006) . Prions can persist in soils for years (Seidel et al., 2007; Brown & Gajdusek, 1991) and binding of PrP TSE by soil particles may maintain prions near the soil surface, thereby increasing animal exposure (Johnson et al., 2006; Cooke et al., 2007; Ma et al., 2007) . Soil particle-associated agents are infectious orally (Seidel et al., 2007; Johnson et al., 2007) . Prion sorption to some types of soil particles enhances oral TSE transmission (Johnson et al., 2007) , providing an explanation for disease transmission despite presumably low levels of prions in soil environments.
Soils comprise complex mixtures of inorganic and organic constituents, and soil properties vary considerably across multiple spatial scales. The influence of soils on prion fate and environmental TSE transmission is expected to be complex, and abiotic soil components may affect the stability of prions present in soil. For example, birnessite group manganese oxide (MnO 2 ) minerals rank among the strongest oxidants in soils (E H 0 51.29 V) (Bricker, 1965) . Soils subjected to alternating reducing and oxidizing conditions, such as those occurring in seasonally waterlogged or poorly drained areas, typically contain the highest accumulations of manganese oxide minerals 3These authors contributed equally to this work.
4Present address: Dipartimento di Scienze del Suolo della Pianta dell'Ambiente e delle Produzioni Animali, Università Federico II, Portici (NA), Italy. (Post, 1999; Tebo et al., 2004) . Well-drained soils may also contain these minerals due to previous wet conditions (McKenzie, 1989) . Manganese III and IV minerals can mediate the transformation of numerous organic compounds, including herbicides (Barrett & McBride, 2005) and antibiotics (Zhang & Huang, 2005; Rubert & Pedersen, 2006) .
As an initial step towards understanding potential abiotic transformations of prions in soil, we investigated PrP TSE degradation by aqueous suspensions of d-MnO 2 , a synthetic manganese oxide mineral equivalent to the birnessite-family mineral vernadite (Villalobos et al., 2003) . Using the method described by Murray (1974) , we synthesized a poorly crystalline manganese oxide resembling d-MnO 2 with an average Mn oxidation state of +3.94 (Gao, 2007) . Brains from clinically affected Syrian hamsters experimentally infected with hamster-adapted transmissible mink encephalopathy agent (HY strain) were used as a source of TSE agent. Brain homogenate (BH), 10 % w/v, was prepared in ddH 2 O and PrP TSE was purified as described previously (Johnson et al., 2006) . For experiments using protein misfolding cyclic amplification (PMCA), PrP TSE was sodium phosphotungstate (PTA)-precipitated from infected BH (Safar et al., 1998) . Protein concentrations were determined using the DC protein assay (Bio-Rad).
PrP
TSE was incubated with suspended d-MnO 2 under ambient O 2 conditions at room temperature for the time periods indicated in the figure legends. Reactions were conducted in 20 mM sodium acetate (pH 4.0), except for experiments examining the effect of pH, in which solutions were buffered with 20 mM sodium acetate (pH 4.0 and 5.0), MES (pH 6.0) or HEPES (pH 7.0 and 8.0). Final sample volumes were 40 ml. Reactions were terminated by dissolving MnO 2 with 25 ml 500 mM EDTA (pH 8.0) at 80 u C. Dissolving of the d-MnO 2 (using ascorbic acid, citric acid or EDTA) liberated proteins, facilitating measurement of remaining protein without affecting PrP TSE levels or detection (data not shown); subsequent experiments used EDTA. The possibility of dissolved d-MnO 2 interfering with PrP TSE detection was examined by dissolving the manganese oxide prior to addition of PrP TSE . After quenching reactions, the pH was stabilized by the addition of 5 ml 1 M Tris/HCl (pH 8.0) to samples. For SDS-PAGE/immunoblot analysis, 20 ml 106 sample buffer (Johnson et al., 2006) was added, and samples were heated for 10 min at 100 u C.
A modification of the method described by Saá et al. (2006) was used for PMCA detection of PrP TSE . Uninfected hamsters were perfused with PBS containing 1 mM EDTA; harvested brains were homogenized to 10 % (w/v) in PBS containing 150 mM NaCl, 1 % Triton X-100, 0.5 % digitonin and complete protease inhibitor cocktail (Roche), then clarified by centrifugation for 5 min at 850 g. Prior to PMCA, PTA-purified PrP TSE (50 mg ml 21 ) was incubated with 5.6 mg d-MnO 2 ml
Dilutions of all samples, in uninfected BH, were aliquoted into 96-well PCR plates then placed at 37 u C in a Misonix 3000 sonicator equipped with a microplate horn. Each of the 120 cycles consisted of 10 s sonication at 80 % power followed by 30 min incubation. Following PMCA, 50 ml sample was mixed with 50 ml 4 % N-lauroyl-sarcosine in PBS and incubated with 40 mg proteinase K ml 21 for 1 h at 37 u C. Proteinase K digestion was terminated by addition of 1 ml phenylmethylsulfonyl fluoride-saturated ethanol. Samples were prepared for immunoblotting by PTA-precipitation and resuspending pellets in 56 sample buffer with 1 % Nlauroyl-sarcosine.
Proteins were fractionated by SDS-PAGE (4-20 % gradient) or 10 % Bistris gel (Invitrogen) for PMCA experiments, transferred to polyvinyl difluoride membranes and immunoblotted with PrP-specific antibodies: mAb 3F4 (1 : 40 000 dilution) or full-length polyclonal antibody Rab 9, pool 2 (1 : 10 000). Detection was achieved with horseradish peroxidase-conjugated goat anti-mouse and anti-rabbit immunoglobulins.
Following 16 h incubation with d-MnO 2 , PrP TSE immunoreactivity declined in proportion to the amount of d-MnO 2 in suspension (Fig. 1a) . At the highest d-MnO 2 concentration tested (5 mg ml is susceptible to degradation; N-terminal cleavage leaves a 27-30 kDa infectious core (Bolton et al., 1982) . When lower d-MnO 2 concentrations were used, the PrP appeared similar in size to the untreated controls, suggesting that d-MnO 2 did not selectively cleave the N terminus (Fig. 1a) . We increased the amount of PrP TSE in the reactions by approximately 10-fold (from 33 to 333 mg ml
21
) to estimate the extent to which d-MnO 2 degrades larger amounts of protein (Fig. 1b) and found that 3 mg d-MnO 2 ml 21 was capable of degrading a considerable fraction of the protein (PrP TSE : d-MnO 2 51 : 90 to 1 : 9). As a control, d-MnO 2 was dissolved prior to incubation with PrP TSE . The amount of PrP TSE present in the dissolved manganese control was substantially larger than in the d-MnO 2 samples, approximately equal to the starting material (Fig. 1b) . These data indicate that d-MnO 2 , not Mn 2+ and EDTA, was responsible for the decrease in immunoreactivity.
The duration of exposure to d-MnO 2 influenced the extent of prion protein loss (Fig. 1c) . Exposure for 1 h to 1.5 or 2.6 mg d-MnO 2 ml 21 (PrP TSE : d-MnO 2 51 : 60 and 1 : 100) had a limited effect on PrP TSE , whereas 24 and 168 h exposures produced substantial declines. Comparable amounts of protein remained after 24 and 168 h exposure to 1.5 mg d-MnO 2 ml 21 , suggesting no further reaction (Fig. 1c) . Decreases in MnO 2 reactivity toward organic molecules over the course of reactions have been noted previously (e.g. Rubert & Pedersen, 2006) and have been attributed to adsorption of reaction products to the oxide surface, shifts in surface site distribution towards less reactive sites or both (Klausen et al., 1997) .
The most probable explanation for the d-MnO 2 -dependent loss of PrP TSE immunoreactivity is degradation of the protein. Birnessite dissolving following the incubation with PrP TSE excludes the possibility that the decreases in immunoblotting signal are due to PrP TSE sorption to mineral surfaces. In the analyses described above, we used the monoclonal antibody (mAb) 3F4, directed against a single epitope on the hydrophobic core of the PrP molecule (residues 109-112). To ensure that the observed declines in PrP TSE were not due to d-MnO 2 affecting the 3F4 epitope, degradation experiments were repeated with 3F4 and a polyclonal antibody directed against full-length PrP (Rab 9, pool 2). After treatment of PrP TSE with d-MnO 2 , no immunoreactivity with Rab 9, pool 2 remained and lower molecular mass breakdown products were absent ( Supplementary Fig. S1 , available in JGV Online). These data are consistent with the hypothesis that d-MnO 2 degrades PrP TSE by breaking the polypeptide backbone of the protein, but do not exclude the possibility that d-MnO 2 also alters amino acid side chains.
Organic molecule degradation by d-MnO 2 typically exhibits pronounced pH dependence (Stone & Morgan, 1984) . We examined the d-MnO 2 -mediated degradation of PrP TSE as a function of pH over the range relevant for most natural soils (pH 4-8) ( Supplementary Fig. S2, Pathogenic prion proteins may be released into the environment in saliva (Mathiason et al., 2006) , excreta (Safar et al., 2008) or from decomposing animal tissue in a complex mixture of biomolecules (Miller et al., 2004) . To evaluate the d-MnO 2 -mediated degradation of PrP TSE in the presence of biological macromolecules, we assessed degradation of infected BH by d-MnO 2 by assaying both total residual protein and PrP TSE (Fig. 2) . Following 16 h ). All blots used mAb 3F4. Extra lanes from the gels in (a) and (c) were excised for clarity of presentation. , little protein was observed on Coomassie brilliant blue-stained gels, and incubation with 3.7 mg d-MnO 2 ml 21 decreased total protein to undetectable levels (detection limit~100 ng protein) (Fig. 2a) . Dissolving of d-MnO 2 prior to incubation with the BH had little effect on protein levels. The PrP TSE present in infected BH was also diminished by exposure to d-MnO 2 (Fig. 2b) . Compared with experiments using preparations enriched in PrP TSE , more dMnO 2 was needed to degrade the PrP TSE in BH (compare Figs 1a and 2b) . This may be due to the reductive dissolution of d-MnO 2 as it reacts with other biomolecules in BH and/or fouling the oxide surface by adsorbed biomolecules.
To semi-quantitatively assess the extent of d-MnO 2 -mediated PrP TSE degradation, we diluted PrP TSE starting material to the limit of immunoblotting detection (Johnson et al., 2006; Hinkley et al., 2008) . A 200-fold dilution of starting material was still detectable on immunoblots (data not shown), thus samples exhibiting no detectable immunoreactivity, such as PrP TSE treated with 5 mg d-MnO 2 ml 21 (Fig. 1a) , contain at least 200-fold less PrP TSE than the starting material. To further assess PrP TSE loss, PMCA was used to determine the amount of PrP converting activity remaining after d-MnO 2 treatment. PMCA sensitively detects prions by measuring the ability of PrP TSE in a sample to convert PrP C to a proteinase Kresistant form (Saá et al., 2006) . Converting activity of the PTA-purified PrP TSE starting material was detectable over four 10-fold dilutions (Fig. 3) . Conversion activity of PTApurified PrP TSE is diminished relative to infected BH ( Fig. 3 and Supplementary Fig. S3 , available in JGV Online), possibly due to increased aggregation of the PTA-purified agent. When samples were incubated with 5.6 mg d-MnO 2 ml 21 (PrP TSE : d-MnO 2 51 : 110) and assayed by PMCA, no converting activity was observed (Fig. 3) . The limit of detection for PMCA is defined by the dilutions of the PTApurified starting material (see above), indicating that 5.6 mg d-MnO 2 ml 21 decreased converting activity by at least four orders of magnitude.
Abiotic processes influence the environmental fate of many contaminants. The data presented here suggest that MnO 2 can degrade PrP TSE in soil environments. Previous studies reported loss of protein from solution when incubated with MnO 2 and ascribed the losses to sorption to MnO 2 surfaces (Naidja et al., 2002; Rao et al., 2007) . Treatment of BH with d-MnO 2 (Fig. 3) indicates that protein degradation is not specific to PrP TSE ; d-MnO 2 degrades most, if not all, brain proteins.
Birnessite-mediated PrP TSE degradation exhibited pronounced pH-dependence ( Supplementary Fig. S2 ). Two non-mutually exclusive factors may have contributed to this behaviour. First, MnO 2 redox potential increases and surface charge becomes less negative as pH declines (Bricker, 1965) . Second, solution pH may influence the degree of protein sorption to MnO 2 surfaces. The point of zero charge for d-MnO 2 occurs near pH 2.3 (Murray, 1974) ; d-MnO 2 particles carried a net negative charge at all pH values examined. Protein attachment to negatively charged surfaces is often maximal at the isoelectric point (pI) of the protein and declines when pH.pI due to repellent electrostatic interactions (Quiquampoix et al., 2002) . The apparent average pI of PrP TSE aggregates is~4.6 (Ma et al., 2007) ; prion protein aggregates carried no net charge around this pH value. In most models of degradation of organic molecules by MnO 2 , sorption to the oxide surface represents a critical initial step (Stone, 1987) . The increase in degradation near the apparent pI of PrP TSE aggregates is consistent with the importance of protein sorption to d-MnO 2 in the overall protein degradation process.
Our data suggest that manganese oxides in soils may promote PrP TSE inactivation, thereby reducing the probability of environmental TSE transmission. Previous investigation of soil manganese contributing to TSE development focused on dietary manganese and copper imbalance (Chihota et al., 2004; Gudmundsdottir et al., 2006; Ragnarsdottir & Hawkins, 2006; McBride, 2007) . Attempts to correlate soil or forage manganese and copper concentrations with TSE incidence have met with limited success. Future attempts to link TSE incidence with soil manganese levels should examine the mineral form of the element in addition to total (or bioavailable) manganese concentration.
Prion fate in terrestrial environments probably depends on soil composition. Abiotic prion degradation could be expected in soil environments rich in MnO 2 , including young, and currently or formerly poorly drained soils (Post, 1999; Tebo et al., 2004 relatively short periods (Fig. 1c) and reduces PrP TSEconverting activity by at least a factor of 10 4 (Fig. 3) . Our findings also suggest that MnO 2 may be effective as a reactive burial material in the disposal of prion-infected materials. Use of MnO 2 for the decontamination of prioncontaminated soils also warrants investigation.
